Dudediligence.

Acumen Pharmaceuticals, Inc

ABOSNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$29.8MSep ’24−$37.2MDec ’24−$28.8MMar ’25−$41.0MJun ’25−$26.5MSep ’25−$25.1MDec ’25−$20.7MMar ’26−$32.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$19.6M−$45.2M−$61.1M−$114.0M−$123.8M
Net income−$100.6M−$42.9M−$52.4M−$102.3M−$121.3M
Operating cash flow−$18.0M−$35.2M−$43.1M−$86.2M−$115.5M
Free cash flow−$18.0M−$35.3M−$43.1M−$86.2M−$115.6M
Cash$122.2M$130.1M$66.9M$35.6M$54.0M
Debtnone on file$0.00$29.9M$29.4M$31.2M
Shares outstanding40.5M41.0M57.9M60.1M60.6M